Ashley Yeager

Ashley started at The Scientist in 2018. Before joining the staff, she worked as a freelance editor and writer, a writer at the Simons Foundation, and a web producer at Science News, among other positions. She holds a bachelor’s degree in journalism from the University of Tennessee, Knoxville, and a master’s degree in science writing from MIT. Ashley edits the Scientist to Watch and Profile sections of the magazine and writes news, features, and other stories for both online and print.

Articles by Ashley Yeager

Infographic: Animals of Different Species Hybridize

Ashley Yeager | | 2 min read

Hybrid Animals Are Not Nature’s Misfits

Ashley Yeager | | 8 min read

Infographic: Envisioning Macrophages

Ashley Yeager | | 1 min read

Macrophages of the Human Eye Come into Focus

Ashley Yeager | | 3 min read

Infographic: A Plant Cell’s Cuticle Helps Regulate Toxic Chemical Accumulation

Ashley Yeager | | 1 min read

Petunia’s Waxy Cuticle Regulates the Plant’s Sweet Smell

Ashley Yeager | | 3 min read

Tardigrades’ List of Super Powers Grows Ever Longer

Ashley Yeager | | 4 min read

Human Fetuses Can Contract SARS-CoV-2, but It’s Rare

Ashley Yeager | | 10+ min read

Steps to End “Colonial Science” Slowly Take Shape

Ashley Yeager | | 10 min read

Infographic: How SARS-CoV-2 Might Travel from Mom to Fetus

Ashley Yeager | | 1 min read

What’s Killing Killer Whales? Autopsies Reveal a Role for Humans

Ashley Yeager | | 4 min read

Eight Proteins Turn Mouse Stem Cells into Egglike Cells

Ashley Yeager | | 3 min read

Page 1 of 29 - 339 Total Items

1 2 3 4 5

Image of a man in a laboratory looking frustrated with his failed experiment.

February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue

Research Resources

Podcasts

Webinars

Videos

Infographics

eBooks

Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

In this half-day virtual summit, a series of presentations will explore the scientific, regulatory, and operational factors impacting the use of in vitro NAMs in drug discovery.

Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

In this webinar, scientists will discuss innovations that are unlocking new insights into immunity.

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

In this webinar, Magdalena Pacewicz will highlight how to use AUC to characterize AAVs as part of ensuring regulatory compliance.

Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

Discover how the latest cancer research models and their applications help scientists pursue breakthrough cancer therapy research.

Products

Product News

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Chief Business Officer Dr. Rob Burgess Shares How Sino Biological Is Empowering Global Biomedical Research Through Precision, Quality, and Innovation on an Exclusive Segment on Fox Business Network airing on February 1, 2026 at 4:30pm EST

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Sino Biological, Inc. has announced the accelerated availability and development of critical research tools to support the global scientific community in combating NiV.

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Collaboration will bring next generation orchestration and modular automation to scientists worldwide

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies

The ranking places Refeyn among a cohort of high-growth UK technology firms spanning sectors including the life sciences, energy and sustainability, telecommunications, and digital technology.